Pharmacology, Pharmacokinetics, Chemotherapy, Oral administration and Paclitaxel are her primary areas of study. Her Pharmacology research includes elements of Camptothecin and Docetaxel. Her Pharmacokinetics study combines topics from a wide range of disciplines, such as Metabolite, Topotecan, Toxicity, Enzyme inhibitor and Drug.
Her research in Chemotherapy intersects with topics in Nausea, Regimen and Vomiting. The Oral administration study combines topics in areas such as Knockout mouse and Multidrug resistance-associated protein 2. Her studies deal with areas such as Oral therapy, Ovarian cancer, Co administration and Antibiotics as well as Paclitaxel.
Her scientific interests lie mostly in Chromatography, Pharmacokinetics, Pharmacology, High-performance liquid chromatography and Tandem mass spectrometry. Her research in Chromatography tackles topics such as Metabolite which are related to areas like Tamoxifen. Her Pharmacokinetics study integrates concerns from other disciplines, such as Paclitaxel, Topotecan, Chemotherapy and Urine.
Her Paclitaxel research incorporates elements of Cyclosporin a and Urology. Her research integrates issues of Excretion and Toxicity in her study of Pharmacology. Her Tandem mass spectrometry research is multidisciplinary, relying on both Electrospray, Therapeutic drug monitoring and Electrospray ionization.
Hilde Rosing mostly deals with Pharmacokinetics, Internal medicine, Chromatography, Oncology and Pharmacology. She works on Pharmacokinetics which deals in particular with Therapeutic drug monitoring. Her Internal medicine research also works with subjects such as
Her Oncology research is multidisciplinary, incorporating elements of Clinical trial, Tamoxifen, Breast cancer, KRAS and Trametinib. Pharmacology and Receptor are commonly linked in her work. Her work carried out in the field of Bioanalysis brings together such families of science as Metabolite, Quantitative determination, Extraction and Mass spectrometry.
Hilde Rosing spends much of her time researching Pharmacokinetics, Internal medicine, Oncology, Chromatography and Pharmacology. Her study in Pharmacokinetics is interdisciplinary in nature, drawing from both Cancer, Chemotherapy, Gemcitabine, MicroDose and Drug. She has researched Chemotherapy in several fields, including Gastroenterology and High-performance liquid chromatography.
Her study looks at the intersection of Internal medicine and topics like DPYD with Capecitabine. Her Chromatography research includes themes of Metabolite and Therapeutic drug monitoring. Her Pharmacology study incorporates themes from Dihydrouracil and Dihydropyrimidine dehydrogenase activity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria
Johan W. Jonker;Marije Buitelaar;Els Wagenaar;Martin A. van der Valk.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?
Ellen Stokvis;Hilde Rosing;Jos H. Beijnen;Jos H. Beijnen.
Rapid Communications in Mass Spectrometry (2005)
Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
C. M.F. Kruijtzer;J. H. Beijnen;H. Rosing;W. W. ten Bokkel Huinink.
Journal of Clinical Oncology (2002)
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients
M.T. Huizing;A.C.F. Keung;H. Rosing;V. van der Kuij.
Journal of Clinical Oncology (1993)
Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel
Jetske M Meerum Terwogt;Wim W ten Bokkel Huinink;Jan Hm Schellens;Margaret Schot.
Anti-Cancer Drugs (2001)
Coadministration of Cyclosporine Strongly Enhances the Oral Bioavailability of Docetaxel
Mirte M. Malingré;Dick J. Richel;Jos H. Beijnen;Hilde Rosing.
Journal of Clinical Oncology (2001)
Multidrug Transporter ABCG2/Breast Cancer Resistance Protein Secretes Riboflavin (Vitamin B2) into Milk
Antonius E. van Herwaarden;Els Wagenaar;Gracia Merino;Johan W. Jonker.
Molecular and Cellular Biology (2007)
Coadministration of oral cyclosporin A enables oral therapy with paclitaxel.
Jetske M. Meerum Terwogt;Mirte M. Malingré;Jos H. Beijnen;Wim W. ten Bokkel Huinink.
Clinical Cancer Research (1999)
BIOANALYTICAL LIQUID CHROMATOGRAPHIC METHOD VALIDATION. A REVIEW OF CURRENT PRACTICES AND PROCEDURES
H. Rosing;W. Y. Man;E. Doyle;A. Bult.
Journal of Liquid Chromatography & Related Technologies (2000)
Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors
A. Taamma;J. L. Misset;M. Riofrio;C. Guzman.
Journal of Clinical Oncology (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: